Clinical Trial Update: Mifepristone as Adjunctive Therapy in Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating mifepristone as adjunctive therapy for Alzheimer's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Mifepristone (mifepristone)

Snippet

Sponsor: Corcept Therapeutics | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED